NANDRO P 100

DESCRIPTION
Nandrolone Phenylpropionate 100 are injectable anabolic preparations containing the short-acting nandrolone phenylpropionate ester. Serum nandrolone levels nel rapidly increase after IM administration with peak serum levels being reached within 24 to 36 hours. NPP clears rapidly avoiding the retention issues associated with the traditional nandrolone decanoate. Nandrolone phenylpropionate accelerates muscle growth, stimulates appetite, increases red blood cell production, and improves bone density.

INDICATIONS
Osteoporosis due to androgen deficiency in hypogonadal males. Treatment of anemia in cases of renal insufficiency where oxymetholone is contraindicated. Restoration of muscle mass in patients with muscular atrophy after traumatic recovery.

ADVERSE REACTIONS
Male: Gynecomastia, excessive frequency and duration of penile erections, oligospermia.
Skin and Appendages: Hirsutism, male pattern baldness and acne, gynecomastia.
Fluid/electrolyte Disturbances: Retention of sodium, chloride, water, potassium, calcium, and inorganic phosphates.
Gastrointestinal: Nausea, cholestatic jaundice, alterations in liver function tests; rarely, hepatocellular neoplasms, peliosis hepatitis, hepatic adenomas, and cholestatic hepatitis.
Hematologic: Suppression of clotting factors II, V, VII, & X; bleeding in patients on anticoagulant therapy.
Nervous System: Increased or decreased libido, headache, anxiety, depression, and generalized paresthesia.
Other: Serum lipid changes, hypercalcaemia, hypertension, oedema, priapism, and potentiation of sleep apnea.

CONTRAINDICATIONS
Not for use in women or children. Patients with known hypersensitivity to any ingredients in this product. Patients with known or suspected prostatic, testicular, hepatic, or mammary carcinoma. Patients with nephrosis or the nephrotic phase of nephritis, hypercalcaemia, oedema, jaundice, or liver or kidney disease with impaired bilirubin excretion. Products containing androgens should not be used in women as they may cause virilization and fetal harm. Latent or overt cardiac failure, renal dysfunction, hypertension, epilepsy or migraine or a history of these conditions, since anabolic steroids may induce salt and fluid retention.

DOSAGE AND ADMINISTRATION
Adult male: 100 – 150 mg injected IM every 3 – 5 days for a duration of 8 to 12 weeks.

PRESENTATION
Nandrolone Phenylpropionate 100 mg/ml, 10 ml multiple dose vial.

STORAGE
Store in a cool dry place between 15- 25°C. Protect from light.